Skip to content

A study of working of Dual Chamber Implantable Pacemaker.

A clinical study for the safety and effectiveness of Dual Chamber Rate Responsive Implantable Pacemaker model CHARAK 747R.

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2016/08/007165
Enrollment
100
Registered
2016-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pacemakers are implanted in the patients having Bradycardia and heartâ??s other electrical problems.

Interventions

Intervention1: Model name Charak 747R: Dual Chamber Rate Responsive Implantable Pulse Generator Intervention2: NIL: NIL Control Intervention1: Charak 747R: Dual Chamber Rate Responsive Implantable Pac

Sponsors

Shree Pacetronix Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Fixed (third degree) AV block 2.Atrial Fibrillation with average Ventricular rate on ECG equal or less than than 40bpm or mean heart rate equal or less than 60bpm. 3.Sinus node Dysfunction with PR interval equal or greater than 300msec 4.Paroxysmal, persistent or permanent AF undergoing AV node , AV node/HIS ablation 5.2°AV Block with equal or greater than 3:1 block 6.The subject is 18 years of age or older 7.The subject has provided written consent for the Pacemaker procedure. 8.Pre-existing Cardiac Permanent pacemaker showing â??Beginning of Lifeâ??.

Exclusion criteria

Exclusion criteria: 1.Pre-existing permanent cardiac pacemaker or ICD (defibrillator) 2.Presence of Hypertrophic Obstructive Cardiomyopathy 3.Recent cardiac surgery (equal or less than 30 days) 4.Recent myocardial infarction (equal or less than 30 days) 5.Presence of mechanical prosthetic tricuspid valve 6.Current or planned pregnancy in the next 6 months. 7.Patients with life expectancy less than 6 months. 8.chronic renal failure

Design outcomes

Primary

MeasureTime frame
1. Complication Rate: The criterion is that the complication rate should be less than 10% for acute phase (During Implantation & hospitalization). 2. Pacing Threshold: It should be less than 2.0V @ 0.4ms Pulse Width. 3. Lead Impedance: It should be between 300 to 1000 ohms. Timepoint: 1. Complication Rate: acute phase (During Implantation & hospitalization). 2. Pacing Threshold: After 6 months of implant. 3. Lead Impedance: It should be between 300 to 1000 ohms. (After 3 months of implant)

Secondary

MeasureTime frame
1. Rate based on activity: The device should show change in rate based on activity as per parameters settings. 2. Anti Tachy therapy (AT): In case of atrial tachycardia the ventricle should stop following atrium and it should come down to base rate. It should not show any inappropriate response. 3. AV Hysteresis: If AV Hysteresis is ON then if R-wave is frequently appearing then pacer should show less percentages of pacing in ventricle. It should not show any inappropriate response. Timepoint: It will checked after 3 months of implant.

Countries

India

Contacts

Public ContactDr Saurabh Mehrotra

PGIMER

ypspgi@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026